|
NEUROMUSCULAR BLOCKING EFFECT IS ENHANCED
|
NEUROMUSCULAR BLOCKING EFFECT IS ENHANCED
|
NEUROMUSCULAR BLOCKING EFFECT IS ENHANCED
|
PARASYMPATHOMIMETICS MAY COUNTERACT EACH OTHER EFFECTS
|
CO-ADMINISTRATION MAY LEAD TO INCREASED PARASYMPHATHOMIMETIC EFFECT CAUSING BRADYCARDIA, HYPOTENSION, A-V CONDUCTION ABNORMALITIES, FLUSHING, DIARRHOEA, ABDOMINAL PAIN, INCREASED SALIVATION ETC
|
FLUCONAZOLE INCREASES SERUM PLASMA CONCENTRATION OF THE DRUG
|
RIFAMPICIN MAY ACCELERATES METABOLISM OF THE DRUG & MAY CAUSE DECREASED PLASMA CONCENTRATION
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
CORTICOSTEROIDS MAY INCREASE EXCRETION OF THE DRUG
|
QUINIDINE MAY INCREASE PLASMA CONCENTRATION OF THE DRUG
|
QUINIDINE MAY INCREASE PLASMA CONCENTRATION OF THE DRUG
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
KETOCONAZOLE MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
MICONAZOLE MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
PHENYTOIN ENHANCES THE DRUG METABOLISM HENCE DECREASED SERUM LEVELS HAVE BEEN OBSERVED
|
CARBAMAZEPINE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
ITRACONAZOLE REDUCES THE DRUG METABOLISM HENCE SERUM LEVELS ARE INCREASED
|
|
|
|
|
|
|